After-hours movers: Chipotle Mexican Grill, Ford, IBM, Edwards Lifesciences, and more
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall St set for higher open as AI stocks rise, oil slides
- Streamflation drives 39% of Americans to cancel streaming in 6 months
Las Vegas Sands (LVS) PT Lowered to $56 at Macquarie
July 25, 2024 8:39 AM EDTMacquarie analyst Chad Beynon lowered the price target on Las Vegas Sands (NYSE: LVS) to $56.00 (from $58.00) while maintaining a Outperform rating.
The analyst comments "2Q miss owing to renovation disruptions in Macau and Singapore. Ongoing construction remains an impact, but sets up for a much... More
TD Cowen Downgrades Edwards Lifesciences (EW) to Hold
July 25, 2024 7:17 AM EDTTD Cowen analyst Joshua Jennings downgraded Edwards Lifesciences (NYSE: EW) from Buy to Hold with a price target of $70.00 (from $100.00).
The analyst comments "We are downgrading EW to Hold as we are now forecasting HSD revenue growth in 2024 and 2025 due to... More
ServiceNow (NOW) PT Raised to $880 at RBC Capital
July 25, 2024 6:39 AM EDTRBC Capital analyst Matthew Hedberg raised the price target on ServiceNow (NYSE: NOW) to $880.00 (from $850.00) while maintaining a Outperform rating.
The analyst comments "Q2/24 showed nice upside and demonstrated impressive cRPO acceleration at scale while the increase in CY/24 subscription revenue guidance conveys the... More
IBM (IBM) PT Raised to $211 at RBC Capital
July 25, 2024 6:35 AM EDTRBC Capital analyst Matthew Swanson raised the price target on IBM (NYSE: IBM) to $211.00 (from $200.00) while maintaining a Outperform rating.
The analyst comments "IBM delivered solid key metrics including upside to FCF which carried through to FY/25 guidance as well as... More
Edwards Lifesciences (EW) PT Lowered to $85 at RBC Capital
July 25, 2024 6:32 AM EDTRBC Capital analyst Shagun Singh lowered the price target on Edwards Lifesciences (NYSE: EW) to $85.00 (from $101.00) while maintaining a Outperform rating.
The analyst comments "EW delivered Q2'24 results missing sales expectations and lowering 2024 operational revenue growth outlook to 8-10%... More
Ford (F) PT Lowered to $17 at Citi
July 25, 2024 5:47 AM EDTCiti analyst Itay Michaeli lowered the price target on Ford (NYSE: F) to $17.00 (from $18.00) while maintaining a Buy rating.
The analyst comments "Q2 disappoints as two issues/risks noted in our preview (here) materialized (1) Cost containment (Q2 missed on another warranty hit); (2)... More
IBM (IBM) PT Raised to $190 at JPMorgan
July 25, 2024 5:10 AM EDTJPMorgan analyst Brian Essex raised the price target on IBM (NYSE: IBM) to $190.00 (from $185.00) while maintaining a Neutral rating.
The analyst comments "Better than expected growth and margin expansion drive an EPS beat and a bump to FY24 FCF guidance. IBM delivered another quarter of better than expected Software growth, healthy AI deal traction, better than expected non-GAAP earnings, and better cash flow. Software performance was supported by Red Hat growth (although decelerated slightly this Q), accelerating Automation growth (aided by inorganic contribution), and better Transaction Processing... More
Edwards Lifesciences (EW) PT Lowered to $76 at Evercore ISI
July 25, 2024 4:59 AM EDTEvercore ISI analyst Vijay Kumar lowered the price target on Edwards Lifesciences (NYSE: EW) to $76.00 (from $91.00) while maintaining a In Line rating.
The analyst comments "Thesis Update: This was tough call for EWthe rev miss, low quality EPS (~5c aid from discrete... More
